From: Prognostic factors in patients with thymoma who underwent surgery
Variable | Univariate analyses | Multivariate analyses | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.153 | 0.474 ~ 2.807 | 0.754 | |||
Gender | 1.936 | 0.853 ~ 4.391 | 0.114 | |||
KPS | 1.647 | 0.736 ~ 3.681 | 0.224 | |||
Smoking | 2.376 | 1.080 ~ 5.227 | 0.031 | 2.989 | 1.142 ~ 7.823 | 0.026 |
Myasthenia gravis | 1.043 | 0.448 ~ 2.429 | 0.922 | |||
Surgical approach | 3.426 | 1.348 ~ 8.704 | 0.01 | 0.838 | 0.171 ~ 4.099 | 0.827 |
Tumor size | 5.597 | 2.062 ~ 15.193 | 0.001 | 4.871 | 1.166 ~ 20.352 | 0.030 |
Resection status | 7.941 | 2.942 ~ 21.432 | < 0.001 | 0.888 | 0.108 ~ 7.289 | 0.912 |
WHO classification | 3.595 | 2.010 ~ 6.428 | < 0.001 | 2.333 | 0.903 ~ 6.025 | 0.080 |
Masaoka-Koga stage | 10.268 | 3.486 ~ 30.250 | < 0.001 | 2.603 | 0.240 ~ 28.231 | 0.432 |
Ki-67 | 1.240 | 0.488 ~ 3.151 | 0.651 | |||
Neutrophil | 1.672 | 0.704 ~ 3.968 | 0.244 | |||
NLR | 1.841 | 0.709 ~ 4.777 | 0.210 | |||
Adjuvant radiotherapy | 6.094 | 2.267 ~ 16.379 | < 0.001 | 2.253 | 0.572 ~ 8.876 | 0.246 |
Adjuvant chemotherapy | 7.407 | 3.223 ~ 17.024 | < 0.001 | 2.631 | 0.688 ~ 10.056 | 0.157 |